Dexamethasone Pediatric Dose — Steroids & Key Indications
Dexamethasone is a potent synthetic corticosteroid with strong anti-inflammatory and minimal mineralocorticoid activity, acting via glucocorticoid receptor-mediated suppression of inflammatory mediators. In pediatric practice, it is commonly used for croup (laryngotracheobronchitis), peri-extubation airway edema prophylaxis, and management of increased intracranial pressure (ICP). Its favorable duration of action and multiple available routes make it a versatile agent across inpatient and emergency settings.
Pediatric Dosing
| Indication | Dose | Route | Frequency / Duration |
|---|---|---|---|
| Croup | 0.6 mg/kg/dose | IV or PO | Single dose |
| Peri-extubation edema | 0.25–0.5 mg/kg/dose (Max 15 mg/dose) | IV | Every 6 hours; do not exceed 24 hours unless directed by attending |
| Increased ICP | 0.5–1 mg/kg/dose | IV | Every 6 hours (adult reference dose: 4–10 mg/dose q6h) |
Worked examples for a 20 kg child:
- Croup: 20 kg × 0.6 mg/kg = 12 mg as a single dose.
- Peri-extubation (mid-range): 20 kg × 0.375 mg/kg = 7.5 mg IV q6h, not to exceed 24 hours.
- Increased ICP (mid-range): 20 kg × 0.75 mg/kg = 15 mg IV q6h.
Indications and Clinical Context
Dexamethasone is a first-line corticosteroid for croup, where a single oral or IV dose reduces subglottic edema and severity scores, decreasing need for hospitalization and repeat interventions. For peri-extubation airway edema, prophylactic dosing every 6 hours (not to exceed 24 hours without attending guidance) aims to attenuate post-extubation stridor in high-risk patients, such as those with prolonged intubation or prior airway trauma.
In the setting of increased intracranial pressure, dexamethasone is used to reduce vasogenic edema—most commonly associated with CNS tumors or certain infectious etiologies. Dosing every 6 hours targets sustained glucocorticoid receptor occupancy. Clinicians should note that adult reference doses (4–10 mg q6h) provide context when weight-based dosing approaches adult thresholds. Consult institutional protocol for duration and taper guidance specific to each indication.
Administration and Monitoring
Dexamethasone may be administered intravenously (IV) as a slow bolus or orally (PO) depending on the indication and clinical context. For croup, the oral route is generally preferred when the child can tolerate it, as bioavailability is excellent and efficacy is equivalent. IV administration is appropriate for peri-extubation and increased ICP indications given the inpatient setting. The maximum single dose for peri-extubation dosing is 15 mg; consult institutional protocol for maximum doses in other indications.
- Adverse effects to monitor: hyperglycemia, hypertension, immunosuppression with prolonged use, gastrointestinal irritation, and behavioral changes (irritability, insomnia).
- Peri-extubation: Duration must not exceed 24 hours unless specifically ordered by the attending physician.
- Increased ICP: Monitor neurological status closely; dexamethasone is most effective for vasogenic rather than cytotoxic edema.
- Contraindications/cautions: Active untreated systemic infection, known hypersensitivity; use with caution in diabetic patients or those at risk for immunocompromise.
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.